Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Gynecologic cancer patients with chronic cancer pain that use opioid drug for basal pain~Exclusion Criteria:~* allergy in fentanyl or morphine~* abnormal cognitive function patient

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Injectable Fentanyl in Sublingual Route (Type: EXPERIMENTAL): Injectable Fentanyl in Sublingual Route that given after the first time Breakthrough Pain is occurred 50 mcg in sublingual route
- Oral Morphine Syrup (Type: ACTIVE_COMPARATOR): Oral Morphine Syrup 2.5 ml ( 5 mg) in oral router that first time given after Breakthrough Pain is occurred

Based on this trial design, predict the completion outcome and termination type (if applicable).